Picture of Ryvu Therapeutics SA logo

RVU Ryvu Therapeutics SA News Story

0.000.00%
pl flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Ryvu Therapeutics Signs Deal With Medical Research Agency For Up to 62.3 Mln Zloty Subsidy

July 31 (Reuters) - Ryvu Therapeutics SA  RVU.WA :
    * SIGNS DEAL WITH MEDICAL RESEARCH AGENCY
    * DEAL ON ABOUT 62.3 MILLION ZLOTY SUBSIDY FOR RIVER-81
PROJECT
    * AIM OF PROJECT IS TO DEVELOP A NEW TREATMENT STRATEGY FOR
ACUTE
MYELOID LEUKEMIA (AML) BY CONDUCTING RIVER-81 STUDY

Source text for Eikon:  ID:nEMxwCJPa 
Further company coverage:  RVU.WA 

 (Reporting by Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; 48 58 769 66 00;))

Recent news on Ryvu Therapeutics SA

See all news